Coexpression cluster:C848
From FANTOM5_SSTAR
Full id: C848_Monocytederived_Mesenchymal_Hepatocyte_Adipocyte_CD14_Cardiac_liver
Phase1 CAGE Peaks
Hg19::chr19:45409042..45409061,+ | p1@APOE |
Hg19::chr19:45411107..45411153,+ | p3@APOE |
Hg19::chr19:45411165..45411180,+ | p5@APOE |
Hg19::chr19:45411811..45411830,+ | p@chr19:45411811..45411830 + |
Hg19::chr19:45411839..45411852,+ | p@chr19:45411839..45411852 + |
Hg19::chr19:45412009..45412026,+ | p@chr19:45412009..45412026 + |
Hg19::chr19:45412466..45412491,+ | p2@AJ249921 |
Hg19::chr19:45417848..45417869,+ | p2@APOC1 |
Hg19::chr2:219646861..219646879,+ | p1@CYP27A1 |
Hg19::chr2:219646891..219646911,+ | p3@CYP27A1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
2.98763831444955e-06 | 0.00101310581536839 | 2 | 29 | Statin Pathway (Wikipathways):WP430 |
3.20096624129033e-06 | 0.00101310581536839 | 2 | 30 | {SDC1,30} (Static Module):NA |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0042157 | lipoprotein metabolic process | 0.00233088563653156 |
GO:0005319 | lipid transporter activity | 0.00233088563653156 |
GO:0006869 | lipid transport | 0.00307992607221813 |
GO:0050749 | apolipoprotein E receptor binding | 0.00347933592370187 |
GO:0047749 | cholestanetriol 26-monooxygenase activity | 0.00347933592370187 |
GO:0048156 | tau protein binding | 0.00579872250488911 |
GO:0031232 | extrinsic to external side of plasma membrane | 0.00745528089466088 |
GO:0033344 | cholesterol efflux | 0.0104327851320064 |
GO:0042627 | chylomicron | 0.0104327851320064 |
GO:0050750 | low-density lipoprotein receptor binding | 0.0104327851320064 |
GO:0045471 | response to ethanol | 0.0104327851320064 |
GO:0006707 | cholesterol catabolic process | 0.0104327851320064 |
GO:0016127 | sterol catabolic process | 0.0104327851320064 |
GO:0048168 | regulation of neuronal synaptic plasticity | 0.0104327851320064 |
GO:0001540 | beta-amyloid binding | 0.0104327851320064 |
GO:0017127 | cholesterol transporter activity | 0.0104327851320064 |
GO:0030516 | regulation of axon extension | 0.0104327851320064 |
GO:0007271 | synaptic transmission, cholinergic | 0.0104327851320064 |
GO:0015248 | sterol transporter activity | 0.0104327851320064 |
GO:0042632 | cholesterol homeostasis | 0.0104327851320064 |
GO:0008395 | steroid hydroxylase activity | 0.0104327851320064 |
GO:0055092 | sterol homeostasis | 0.0104327851320064 |
GO:0048167 | regulation of synaptic plasticity | 0.0104327851320064 |
GO:0006706 | steroid catabolic process | 0.0104327851320064 |
GO:0051262 | protein tetramerization | 0.0104327851320064 |
GO:0048675 | axon extension | 0.0104327851320064 |
GO:0055088 | lipid homeostasis | 0.0104327851320064 |
GO:0015918 | sterol transport | 0.0104327851320064 |
GO:0050803 | regulation of synapse structure and activity | 0.0104327851320064 |
GO:0030301 | cholesterol transport | 0.0104327851320064 |
GO:0042311 | vasodilation | 0.0106568323372062 |
GO:0006629 | lipid metabolic process | 0.0136963903325708 |
GO:0050770 | regulation of axonogenesis | 0.0136963903325708 |
GO:0000302 | response to reactive oxygen species | 0.0138044394409538 |
GO:0044444 | cytoplasmic part | 0.013892968335835 |
GO:0008034 | lipoprotein binding | 0.014002444188512 |
GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen | 0.0159706137010346 |
GO:0050767 | regulation of neurogenesis | 0.017377738469733 |
GO:0035150 | regulation of tube size | 0.0182020333822998 |
GO:0050880 | regulation of blood vessel size | 0.0182020333822998 |
GO:0003018 | vascular process in circulatory system | 0.0182020333822998 |
GO:0007611 | learning and/or memory | 0.0182020333822998 |
GO:0044242 | cellular lipid catabolic process | 0.0193017759435435 |
GO:0019897 | extrinsic to plasma membrane | 0.0193017759435435 |
GO:0009897 | external side of plasma membrane | 0.0193017759435435 |
GO:0042158 | lipoprotein biosynthetic process | 0.0207673309043863 |
GO:0051259 | protein oligomerization | 0.022430385414656 |
GO:0010033 | response to organic substance | 0.022430385414656 |
GO:0008201 | heparin binding | 0.0269230771158613 |
GO:0008203 | cholesterol metabolic process | 0.0270773521657405 |
GO:0035239 | tube morphogenesis | 0.0285834033885244 |
GO:0022892 | substrate-specific transporter activity | 0.0296339091377412 |
GO:0016125 | sterol metabolic process | 0.0307700964873075 |
GO:0019898 | extrinsic to membrane | 0.0323047891962794 |
GO:0005539 | glycosaminoglycan binding | 0.0323047891962794 |
GO:0007409 | axonogenesis | 0.0323047891962794 |
GO:0006874 | cellular calcium ion homeostasis | 0.0323047891962794 |
GO:0055074 | calcium ion homeostasis | 0.0323047891962794 |
GO:0030247 | polysaccharide binding | 0.0323047891962794 |
GO:0035295 | tube development | 0.0323047891962794 |
GO:0048667 | neuron morphogenesis during differentiation | 0.0323047891962794 |
GO:0006979 | response to oxidative stress | 0.0323047891962794 |
GO:0048812 | neurite morphogenesis | 0.0323047891962794 |
GO:0005737 | cytoplasm | 0.0323047891962794 |
GO:0006875 | cellular metal ion homeostasis | 0.0323047891962794 |
GO:0055065 | metal ion homeostasis | 0.0323047891962794 |
GO:0000904 | cellular morphogenesis during differentiation | 0.0323704952536164 |
GO:0001871 | pattern binding | 0.0323704952536164 |
GO:0031175 | neurite development | 0.0339028968136092 |
GO:0016042 | lipid catabolic process | 0.0361068058286039 |
GO:0009986 | cell surface | 0.0361068058286039 |
GO:0048666 | neuron development | 0.0370422287137999 |
GO:0008015 | blood circulation | 0.0374386623722683 |
GO:0003013 | circulatory system process | 0.0374386623722683 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.0408438217093907 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0409859363824008 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0411242406834246 |
GO:0043231 | intracellular membrane-bound organelle | 0.041997112304992 |
GO:0043227 | membrane-bound organelle | 0.041997112304992 |
GO:0030003 | cellular cation homeostasis | 0.041997112304992 |
GO:0055080 | cation homeostasis | 0.041997112304992 |
GO:0032990 | cell part morphogenesis | 0.041997112304992 |
GO:0048858 | cell projection morphogenesis | 0.041997112304992 |
GO:0030030 | cell projection organization and biogenesis | 0.041997112304992 |
GO:0030182 | neuron differentiation | 0.0423266215631961 |
GO:0006917 | induction of apoptosis | 0.0423266215631961 |
GO:0012502 | induction of programmed cell death | 0.0423266215631961 |
GO:0008202 | steroid metabolic process | 0.043797299095766 |
GO:0004497 | monooxygenase activity | 0.0445047405106417 |
GO:0050793 | regulation of developmental process | 0.0445047405106417 |
GO:0055082 | cellular chemical homeostasis | 0.0445047405106417 |
GO:0006873 | cellular ion homeostasis | 0.0445047405106417 |
GO:0048699 | generation of neurons | 0.0449483858556084 |
GO:0043065 | positive regulation of apoptosis | 0.0468891903292327 |
GO:0043068 | positive regulation of programmed cell death | 0.0468891903292327 |
GO:0022008 | neurogenesis | 0.0471145908048725 |
GO:0050801 | ion homeostasis | 0.0475117257202813 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
stuff accumulating cell | 4.63e-08 | 39 |
pigment cell | 1.58e-07 | 14 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.